Lombard Odier Asset Management (Switzerland)’s AbbVie ABBV Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2026
Q1 | $17.5M | Buy |
80,658
+6,900
| +9% | +$1.53M | 0.67% | 24 |
|
|
2025
Q4 | $16.9M | Buy |
73,758
+10,000
| +16% | +$2.28M | 0.72% | 22 |
|
|
2025
Q3 | $14.8M | Buy |
63,758
+2,835
| +5% | +$577K | 0.67% | 24 |
|
|
2025
Q2 | $11.3M | Sell |
60,923
-1,770
| -3% | -$329K | 0.57% | 34 |
|
|
2025
Q1 | $13.1M | Buy |
62,693
+4,116
| +7% | +$800K | 0.75% | 27 |
|
|
2024
Q4 | $10.4M | Buy |
58,577
+5,352
| +10% | +$984K | 0.78% | 20 |
|
|
2024
Q3 | $10.5M | Buy |
53,225
+1,504
| +3% | +$281K | 0.88% | 20 |
|
|
2024
Q2 | $8.87M | Sell |
51,721
-558
| -1% | -$92.4K | 0.9% | 17 |
|
|
2024
Q1 | $9.52M | Buy |
52,279
+28,093
| +116% | +$4.84M | 0.67% | 39 |
|
|
2023
Q4 | $3.75M | Buy |
24,186
+7,259
| +43% | +$1.06M | 0.5% | 59 |
|
|
2023
Q3 | $2.52M | Buy |
16,927
+2,194
| +15% | +$322K | 0.41% | 63 |
|
|
2023
Q2 | $1.98M | Sell |
14,733
-520
| -3% | -$76.3K | 0.28% | 71 |
|
|
2023
Q1 | $2.43M | Buy |
15,253
+856
| +6% | +$131K | 0.21% | 116 |
|
|
2022
Q4 | $2.33M | Sell |
14,397
-115,331
| -89% | -$17.7M | 0.19% | 111 |
|
|
2022
Q3 | $17.4M | Sell |
129,728
-5,758
| -4% | -$826K | 1.48% | 22 |
|
|
2022
Q2 | $20.8M | Sell |
135,486
-76,474
| -36% | -$11.7M | 1.76% | 16 |
|
|
2022
Q1 | $34.4M | Sell |
211,960
-25,524
| -11% | -$3.71M | 2.7% | 1 |
|
|
2021
Q4 | $32.2M | Buy |
237,484
+21,345
| +10% | +$2.52M | 2.05% | 7 |
|
|
2021
Q3 | $23.2M | Sell |
216,139
-25,000
| -10% | -$2.86M | 1.44% | 29 |
|
|
2021
Q2 | $27.2M | Buy |
241,139
+28,310
| +13% | +$3.19M | 1.38% | 14 |
|
|
2021
Q1 | $23M | Sell |
212,829
-88,172
| -29% | -$9.43M | 1.53% | 19 |
|
|
2020
Q4 | $32.3M | Buy |
301,001
+35,243
| +13% | +$3.39M | 3.64% | 2 |
|
|
2020
Q3 | $23.3M | Buy |
265,758
+94,436
| +55% | +$8.89M | 2.45% | 5 |
|
|
2020
Q2 | $16.8M | Buy |
171,322
+153,126
| +842% | +$13.5M | 2.6% | 8 |
|
|
2020
Q1 | $1.39M | Buy |
18,196
+12,769
| +235% | +$1.09M | 0.19% | 87 |
|
|
2019
Q4 | $481K | Sell |
5,427
-6,607
| -55% | -$549K | 0.05% | 250 |
|
|
2019
Q3 | $911K | Buy |
12,034
+6,819
| +131% | +$468K | 0.1% | 175 |
|
|
2019
Q2 | $379K | Hold |
5,215
| – | – | 0.04% | 261 |
|
|
2019
Q1 | $420K | Hold |
5,215
| – | – | 0.04% | 259 |
|
|
2018
Q4 | $481K | Hold |
5,215
| – | – | 0.05% | 234 |
|
|
2018
Q3 | $493K | Sell |
5,215
-4,375
| -46% | -$415K | 0.05% | 243 |
|
|
2018
Q2 | $889K | Hold |
9,590
| – | – | 0.09% | 188 |
|
|
2018
Q1 | $908K | Sell |
9,590
-96,970
| -91% | -$10.7M | 0.09% | 192 |
|
|
2017
Q4 | $10.3M | Sell |
106,560
-139,000
| -57% | -$13.1M | 1% | 24 |
|
|
2017
Q3 | $21.8M | Buy |
245,560
+60,963
| +33% | +$4.64M | 2.12% | 6 |
|
|
2017
Q2 | $13.4M | Buy |
184,597
+70,537
| +62% | +$4.74M | 1.54% | 18 |
|
|
2017
Q1 | $7.43M | Buy |
+114,060
| New | +$7.17M | 0.82% | 37 |
|
|
2016
Q3 | – | Sell |
-6,560
| Closed | -$406K | – | 104 |
|
|
2016
Q2 | $406K | Sell |
6,560
-3,014
| -31% | -$184K | 0.06% | 209 |
|
|
2016
Q1 | $547K | Hold |
9,574
| – | – | 0.07% | 184 |
|
|
2015
Q4 | $573K | Sell |
9,574
-150,000
| -94% | -$8.64M | 0.07% | 169 |
|
|
2015
Q3 | $8.69M | Sell |
159,574
-62,807
| -28% | -$4.09M | 0.79% | 28 |
|
|
2015
Q2 | $14.9M | Buy |
222,381
+210,906
| +1,838% | +$13.8M | 1.12% | 22 |
|
|
2015
Q1 | $675K | Buy |
+11,475
| New | +$693K | 0.08% | 256 |
|
|
2014
Q4 | – | Sell |
-250,520
| Closed | -$14.5M | – | 404 |
|
|
2014
Q3 | $14.5M | Buy |
250,520
+238,354
| +1,959% | +$13.2M | 0.37% | 68 |
|
|
2014
Q2 | $683K | Buy |
+12,166
| New | +$638K | 0.08% | 170 |
|
Other funds holding ABBV
VCM
VPM
Lombard Odier Asset Management (Switzerland)'s ABBV Position: Q1 2026 in Review
Lombard Odier Asset Management (Switzerland) increased its AbbVie (ABBV) stake by 9.4% in Q1 2026, buying an estimated $1.53M and bringing the position to 80,658 shares worth $17.5M. The position accounts for 0.67% of the portfolio, ranked #24.
Lombard Odier Asset Management (Switzerland) first reported a position in ABBV in Q2 2014 and has held it in 45 quarters since. The position peaked at $34.4M in Q1 2022. 4,087 funds tracked by Wall St. Rank hold ABBV as of Q1 2026.
- Lombard Odier Asset Management (Switzerland) held 80,658 shares of AbbVie worth $17.5M as of Q1 2026.
- Lombard Odier Asset Management (Switzerland) bought 6,900 AbbVie shares in Q1 2026, an estimated $1.53M.
- AbbVie made up 0.67% of Lombard Odier Asset Management (Switzerland)'s portfolio in Q1 2026, its #24 holding.
- Lombard Odier Asset Management (Switzerland) first reported a position in AbbVie in Q2 2014 and has held it in 45 quarters since.
- Lombard Odier Asset Management (Switzerland)'s AbbVie position peaked at $34.4M in Q1 2022.
- 4,087 funds tracked by Wall St. Rank held AbbVie as of Q1 2026.
Based on Lombard Odier Asset Management (Switzerland)'s 13F filing for Q1 2026, filed 15 May 2026.